151 results on '"Pachter J"'
Search Results
2. The RAF/MEK clamp VS-6766 shows strong anti-tumor activity across multiple MAPK pathway alterations, with a preferential effect on KRAS G12V
3. Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma
4. P52.05 Dual RAF/MEK Inhibitor VS-6766 for Treatment of KRAS Mutant NSCLC: Novel Combinations Targeting G12C or G12V Variants
5. Inflammatory mechanisms in Alzheimer disease: the role of beta-amyloid/glial interactions
6. Heterogeneity of the CNS microvasculature: C06-1
7. 52 (PB042) - The RAF/MEK clamp VS-6766 shows strong anti-tumor activity across multiple MAPK pathway alterations, with a preferential effect on KRAS G12V
8. Caveolae are involved in the response of astrocytes to MCP-1
9. PATTERNS OF DUVELISIB-INDUCED LYMPHOCYTOSIS IN PATIENTS WITH R/R CLL OR SLL INCLUDING THOSE WITH HIGH-RISK FACTORS TREATED IN THE DUO TRIAL
10. PS1160 PATTERNS OF DUVELISIB-INDUCED LYMPHOCYTOSIS IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA INCLUDING THOSE WITH HIGH-RISK FACTORS TREATED IN THE DUO TRIAL
11. Abstract P2-06-07: Investigating the role of focal adhesion kinase in regulating CSC activity in invasive ductal carcinoma
12. Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia
13. Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma
14. 280 FAK inhibitor defactinib (VS-6063) targets mesothelioma cancer stem cells: Rationale for maintenance therapy after conventional chemotherapy
15. 281 VS-5584, a dual PI3K/mTOR inhibitor, demonstrates robust activity in pre-clinical models of SCLC with the inhibition of both cancer stem cells and bulk tumor cells
16. 302 FAK inhibitor VS-6063 (defactinib) targets mesothelioma cancer stem cells which are enriched by standard of care chemotherapy
17. 439 PI3K/mTOR inhibitor VS-5584 targets cancer stem cells and prevents tumor regrowth after chemotherapy in preclinical models of small cell lung cancer
18. ACK1 kinase in complex with the inhibitor cis-3-[8-amino-1-(4-phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
19. Autopilots for flying circular paths
20. Energy preserving formation flight control
21. 346 Activated RON tyrosine kinase drives cellular proliferation, migration and invasion with corresponding tumor growth and metastasis in mice
22. OR13,78 Compensatory activation of insulin receptor (IR) upon inhibition of insulin-like growth factor-1 receptor (IGF-1R): Rationale for co-targeting IGF-1R and IR in cancer
23. 90 POSTER Differential effects of blockade of the HER3-PI3K-Akt pathway by EGFR kinase inhibitors and EGFR monoclonal antibodies on combinations with IGF-1R kinase inhibition
24. 325 POSTER Erlotinib, an EGFR kinase inhibitor, sensitizes mesenchymal-like tumor cells to the actions of OXA-01, a selective non-macrolide inhibitor of mTORC1/mTORC2
25. CCR2 expression by brain microvascular endothelial cells is critical for macrophage transendothelial migration in response to CCL2
26. Neurocytopathic effects of beta-amyloid-stimulated monocytes: a potential mechanism for central nervous system damage in Alzheimer disease.
27. Autopilots for flying circular paths
28. Energy preserving formation flight control
29. Endothelin (ETA) receptor number and calcium signalling are up-regulated by protein kinase C-β 1 overexpression
30. The blood-brain barrier: geriatric relevance of a critical brain--body interface.
31. Overexpression of protein kinase C beta 1 enhances phospholipase D activity and diacylglycerol formation in phorbol ester-stimulated rat fibroblasts.
32. Multiple receptors coupled to adenylate cyclase regulate Na-H exchange independent of cAMP.
33. Thapsigargin, but not caffeine, blocks the ability of thyrotropin-releasing hormone to release Ca2+ from an intracellular store in GH4C1 pituitary cells
34. Autoregulated changes in stability of polyribosome-bound beta-tubulin mRNAs are specified by the first 13 translated nucleotides
35. TRH and BAY K 8644 synergistically stimulate prolactin release but not 45Ca2+ uptake
36. DNA binding studies on several new anthracycline antitumor antibiotics II. The importance of the carbomethoxy-group as position-10 of the class II anthracycline molecule.
37. Suppression of A -induced monocyte neurotoxicity by antiinflammatory compounds
38. A rapid and sensitive radioimmunoassay for the detection of human cytomegalovirus binding and infection of human fibroblasts
39. Autoregulated changes in stability of polyribosome-bound beta-tubulin mRNAs are specified by the first 13 translated nucleotides
40. Macrophages/microglial cells in human central nervous system during development: an immunohistochemical study
41. Noncompetitive inhibition of inositol monophosphatase by K-76 monocarboxylic acid.
42. alpha-Internexin, a 66-kD intermediate filament-binding protein from mammalian central nervous tissues.
43. beta-Internexin, a ubiquitous intermediate filament-associated protein.
44. D~4 Dopamine Receptor-Selective Compounds from the Chinese Plant Phoebe Chekiangensis
45. Intracellular distribution of mammalian stress proteins. Effects of cytoskeletal-specific agents.
46. Marine sponge bis(indole) alkaloids that displace ligand binding to a1 adrenergic receptors
47. Autoregulation of tubulin expression is achieved through specific degradation of polysomal tubulin mRNAs
48. Colloquium C06: The Blood Brain Barrier and it's Role in Immune Priviledge in the CNS in Health and Disease.
49. Active induction of experimental autoimmune encephalomyelitis by MOG35-55 peptide immunization is associated with differential responses in separate compartments of the choroid plexus
50. The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.